✨ Latest Business

Pfizer Beats Q4 2025 Estimates as Non-COVID Growth Fuels Momentum

#pfizer #biopharma #investing #outlook #vaccines

Pfizer beats Q4 2025 estimates on non-COVID growth and outlines a steady 2026 outlook across vaccines, oncology, and more.

• Read More